Prostate cancer‐specific survival ‐ not reported
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Urinary quality of life (short‐term)
1 finding from 1 review
Sexual quality of life
1 finding from 1 review
Biochemical recurrence‐free survival ‐ not reported
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall survival ‐ not reported
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall rate of surgical complications
Laparaoscopic radical prostatectomy and robotic‐assisted… showed no clear difference in overall surgical complications (short‐term) compared with open radical prostatectomy (low certainty).
1 finding from 1 review
Urinary continence within 1 week after catheter removal MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Posterior reconstruction showed no clear difference in urinary continence within 1 week after catheter removal MCID: 5%… compared with no posterior reconstruction (low certainty).
1 finding from 1 review
Urinary continence 3 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Posterior reconstruction showed no clear difference in urinary continence 3 months after surgery MCID: 5% absolute difference compared with no posterior reconstruction (low certainty).
1 finding from 1 review
Serious adverse events · men (ages > 18 years) with clinically localized prostate cancer
Posterior reconstruction showed no clear difference in serious adverse events compared with no posterior reconstruction (moderate certainty).
1 finding from 1 review
Urinary continence 6 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Posterior reconstruction showed no clear difference in urinary continence 6 months after surgery MCID: 5% absolute difference compared with no posterior reconstruction (moderate certainty).
1 finding from 1 review
Urinary continence 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Posterior reconstruction showed no clear difference in urinary continence 12 months after surgery MCID: 5% absolute… compared with no posterior reconstruction (low certainty).
1 finding from 1 review
Potency 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
It is very uncertain whether posterior reconstruction changes potency recovery 12 months after surgery MCID: 5% absolute difference compared with no posterior reconstruction (very low certainty).
1 finding from 1 review
Positive surgical margins MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Posterior reconstruction showed no clear difference in positive surgical margins MCID: 5% absolute difference compared with no posterior reconstruction (low certainty).
1 finding from 1 review
Urinary continence within 1 week after catheter removal MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP probably leads to higher urinary continence within 1 week after catheter removal MCID: 5%… compared with standard RALP (moderate certainty).
1 finding from 1 review
Urinary continence 3 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP may leads to higher urinary continence 3 months after surgery MCID: 5% absolute difference compared with standard RALP (low certainty).
1 finding from 1 review
Serious adverse events · men (ages > 18 years) with clinically localized prostate cancer
It is very uncertain whether retzius‐sparing RALP changes serious adverse events compared with standard RALP (very low certainty).
1 finding from 1 review
Urinary continence 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP showed no clear difference in urinary continence 12 months after surgery MCID: 5% absolute… compared with standard RALP (moderate certainty).
1 finding from 1 review
Potency 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
It is very uncertain whether retzius‐sparing RALP changes potency 12 months after surgery MCID: 5% absolute difference compared with standard RALP (very low certainty).
1 finding from 1 review
Positive surgical margins MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP may leads to higher positive surgical margins MCID: 5% absolute difference compared with standard RALP (low certainty).
1 finding from 1 review
Biochemical recurrence‐free survival · men (ages > 18 years) with clinically localized prostate cancer
It is very uncertain whether retzius‐sparing RALP changes biochemical recurrence‐free survival compared with standard RALP (very low certainty).
1 finding from 1 review